QID 353057

Date Published: 2021-12-14

QID 353057: Amazon Linux Security Advisory for docker : ALAS2NITRO-ENCLAVES-2021-001

A flaw was found in the `userns-remap` feature of docker.
The root user in the remapped namespace can modify files under /var/lib/docker/<remapping>, leading to possible privilege escalation to the root user in the host.
The highest threat from this vulnerability is to data integrity. (
( CVE-2021-21284) a flaw was found in docker.
Pulling an intentionally malformed docker image manifest could lead to a crash of the `dockerd` daemon, resulting in a denial of service.
The highest threat from this vulnerability is to system availability. (
( CVE-2021-21285)



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a securitybreach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as High - 6.8 severity.
  • CVSS V2 rated as Low - 2.7 severity.
    • Solution
    Please refer to Amazon advisory: ALAS2NITRO-ENCLAVES-2021-001 for affected packages and patching details, or update with your package manager.
    Vendor References

    CVEs related to QID 353057

    CVE-2021-21285 | CVE-2021-21284 |
    Software Advisories
    Advisory ID Software Component Link
    ALAS2NITRO-ENCLAVES-2021-001 Amazon Linux 2 URL Logo alas.aws.amazon.com/AL2/ALASNITRO-ENCLAVES-2021-001.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].